We first examined HIG2 mRNA levels by qPCR in a cohort of glioma samples, including 14 grade II astrocytomas (A), 15 grade III anaplastic astrocytomas (AA), 31 grade IV GBMs and 5 normal brain samples. This evidence concerns the gene HILPDA and central nervous system cancer.